Glaxosmithkline Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 75.00% of Glaxosmithkline Pharmaceuticals, FIIs hold 4.75%, DIIs hold 8.47% and the public holds 11.77%. Promoter holding was unchanged from Jun 2026.
Get an alert when Glaxosmithkline Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
75.00%
unchanged QoQ
FIIs
4.75%
−0.04 pp QoQ
DIIs
8.47%
+0.66 pp QoQ
Public
11.77%
−0.65 pp QoQ
Glaxosmithkline Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Government | Public | Shareholders |
|---|---|---|---|---|---|---|
| Sep 2026 | 75.00% | 4.75% | 8.47% | 0.00% | 11.77% | 1,19,337 |
| Jun 2026 | 75.00% | 4.79% | 7.81% | 0.00% | 12.42% | 1,26,087 |
| Mar 2026 | 75.00% | 4.62% | 7.68% | 0.00% | 12.69% | 1,21,763 |
| Dec 2025 | 75.00% | 4.63% | 7.70% | 0.00% | 12.67% | 1,22,460 |
| Sep 2025 | 75.00% | 4.79% | 7.75% | 0.00% | 12.45% | 1,22,904 |
| Jun 2025 | 75.00% | 4.89% | 7.71% | 0.00% | 12.41% | 1,23,629 |
| Mar 2025 | 75.00% | 4.52% | 7.79% | 0.00% | 12.69% | 1,21,885 |
| Dec 2024 | 75.00% | 4.50% | 7.30% | 0.00% | 13.21% | 1,19,625 |
| Sep 2024 | 75.00% | 4.36% | 7.34% | 0.00% | 13.30% | 1,19,228 |
| Jun 2024 | 75.00% | 4.02% | 7.51% | 0.00% | 13.48% | 1,18,515 |
| Mar 2024 | 75.00% | 3.48% | 7.90% | 0.00% | 13.62% | 1,18,994 |
| Dec 2023 | 75.00% | 2.93% | 8.64% | 0.01% | 13.42% | 1,14,663 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹45.27k cr, the promoter group's 75.00% stake is worth ₹33.96k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Glaxosmithkline Pharmaceuticals shareholding: common questions
What is the promoter holding in Glaxosmithkline Pharmaceuticals?
Promoters hold 75.00% of Glaxosmithkline Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Glaxosmithkline Pharmaceuticals?
Foreign institutional investors (FIIs) held 4.75% of Glaxosmithkline Pharmaceuticals in Sep 2026, −0.04 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Glaxosmithkline Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 8.47% of Glaxosmithkline Pharmaceuticals in Sep 2026, +0.66 pp versus Jun 2026.
Is the promoter holding in Glaxosmithkline Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Glaxosmithkline Pharmaceuticals.
How has Glaxosmithkline Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 75.00% in Sep 2025 to 75.00% in Sep 2026 (unchanged).
How many shareholders does Glaxosmithkline Pharmaceuticals have?
Glaxosmithkline Pharmaceuticals had 1,19,337 shareholders in Sep 2026, compared with 1,26,087 in Jun 2026.